Long-term results of human atrial natriuretic peptide in patients with chronic kidney disease undergoing coronary artery bypass grafting: the NU-HIT trial for CKD | Zendy

AI Assistant Blog Pricing

Long-term results of human atrial natriuretic peptide in patients with chronic kidney disease undergoing coronary artery bypass grafting: the NU-HIT trial for CKD

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.